Skip to main content
. 2016 Jul 30;6(9):902–913. doi: 10.1002/2211-5463.12078

Figure 3.

Figure 3

Plasma gpNMB in type 1 GD patients. (A) Western blot detection of gpNMB in 0.5 μL type 1 GD and control plasma. (B) ELISA quantification of gpNMB in type 1 GD (squares) and control plasma (circles). (C) Correlation of plasma gpNMB and glucosylceramide (GlcCer). (D) Correlation of plasma gpNMB and glucosylsphingosine (Glc‐Spho). (E) Correlation of plasma gpNMB and chitotriosidase. (F) Correlation of plasma gpNMB and CCL18.